EGYPTIAN FAMILY OF SIX REARRESTED AFTER ICE RELEASE, LAWYER WARNS OF FAST-TRACK DEPORTATION DESPITE COURT-ORDERED PAUSE AND ONGOING ASYLUM CASE. (PHOTO).

Image
 Egyptian family of six rearrested after ICE release, lawyer warns of fast-track deportation despite court-ordered pause and ongoing asylum case An Egyptian family of six who had recently been released from immigration custody was rearrested Saturday, with their attorney warning they could face rapid deportation despite a court order temporarily pausing their removal. The family—Hayam El Gamal and her five children—had spent roughly ten months in the Dilley detention center outside San Antonio, Texas, where conditions have drawn criticism over access to food and medical care. A federal magistrate judge had ruled earlier this week that the family should be released while their asylum case proceeds after they entered the United States in 2022 on a tourist visa. Following Saturday’s rearrest, their attorney said they were placed on a flight to Michigan and could then be transferred for deportation to Egypt. He argued in a court filing and public statement that the move violated judici...

TRUMP APPROVES 'NO-COST' MARIJUANA PRODUCTS FOR MEDICARE RECIPIENTS. (PHOTO).


 Trump approves 'no-cost' marijuana products for Medicare recipients

 President Trump signed an executive order Thursday initiating a pilot program that allows Medicare to cover cannabis products for seniors, marking a significant policy shift in federal support for medical marijuana.

The move could provide older Americans with alternative treatments for common ailments, at a time when marijuana use among adults 65 and older is rising sharply. A 2023 NYU study found that 7% of adults in that age group reported using marijuana in the past month, up from 4.8% in 2021 and 5.2% in 2022, representing nearly a 46% increase in two years.

Under the order, marijuana will be reclassified as a Schedule III drug by the Drug Enforcement Administration, placing it alongside medications such as Tylenol with codeine, rather than Schedule I drugs like heroin and LSD. The pilot program will specifically cover cannabidiol (CBD) products for Medicare beneficiaries, with coverage expected to begin as early as April next year if recommended by a doctor. CMS Administrator Mehmet Oz confirmed that Medicare Advantage insurers are also expected to consider CBD coverage for the roughly 34 million Americans they insure.

Trump said the policy recognizes marijuana’s potential medical applications, including as a substitute for addictive and potentially dangerous opioids. While proponents praise the program as a step forward, experts caution that long-term CBD use can carry risks, including liver toxicity and interference with other medications. Advocates see the initiative as a significant opening in federal policy toward medical cannabis, while some medical specialists argue the focus on CBD over THC ignores decades of research supporting THC’s therapeutic uses.

The administration is considering expanding coverage if the pilot program proves successful, potentially extending access to more conditions and Medicaid beneficiaries as well. This marks the latest in a series of moves by the federal government to re-examine cannabis policy, following recommendations from HHS to loosen restrictions and reclassify marijuana.


Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

AMBODE,SOYINKA & OTHERS AT THE OFFICIAL LAUNCH OF LAGOS AT 50 YEARS ANNIVERSARY AGAINST 2017.{PHOTOS}.